Fusion Pharmaceuticals Inc. Deferred Tax Assets, Net
Fusion Pharmaceuticals Inc. had Deferred Tax Assets, Net of $3.96 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsLiabilitiesNet · last filed 2024-03-20
- 2023-12-31: Deferred Tax Assets, Net $3.96M.
- 2022-12-31: Deferred Tax Assets, Net $4.81M.
- 2021-12-31: Deferred Tax Assets, Net $1.65M.
- 2020-12-31: Deferred Tax Assets, Net $653.00K.
| Period end | Deferred Tax Assets, Net |
|---|---|
| 2023-12-31 | $3.96M 10-K · filed 2024-03-20 |
| 2022-12-31 | $4.81M 10-K · filed 2024-03-20 |
| 2021-12-31 | $1.65M 10-K · filed 2023-03-16 |
| 2020-12-31 | $653.00K 10-K · filed 2022-03-17 |
| 2019-12-31 | $78.00K 10-K · filed 2021-03-25 |